Qube Research & Technologies (QRT)
CL icon

Qube Research & Technologies (QRT)’s Colgate-Palmolive CL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206M Buy
2,421,293
+2,097,037
+647% +$187M 0.23% 92
2025
Q4 		$25.6M Sell
324,256
-2,608,044
-89% -$204M 0.03% 790
2025
Q3 		$234M Buy
2,932,300
+737,222
+34% +$62.9M 0.24% 73
2025
Q2 		$200M Sell
2,195,078
-2,133,455
-49% -$195M 0.2% 104
2025
Q1 		$406M Buy
4,328,533
+1,206,741
+39% +$108M 0.47% 30
2024
Q4 		$284M Buy
3,121,792
+2,242,340
+255% +$214M 0.37% 37
2024
Q3 		$91.3M Buy
+879,452
New +$89.6M 0.13% 165
2024
Q1 		– Sell
-269,795
Closed -$21.5M – 4505
2023
Q4 		$21.5M Sell
269,795
-1,463,639
-84% -$110M 0.04% 490
2023
Q3 		$123M Sell
1,733,434
-214,672
-11% -$16.1M 0.32% 68
2023
Q2 		$150M Buy
1,948,106
+1,170,966
+151% +$90.6M 0.55% 23
2023
Q1 		$58.4M Buy
777,140
+434,764
+127% +$32.3M 0.25% 68
2022
Q4 		$27M Sell
342,376
-296,479
-46% -$22.2M 0.14% 191
2022
Q3 		$44.9M Buy
+638,855
New +$50.1M 0.27% 84
2022
Q2 		– Sell
-341,698
Closed -$25.9M – 2565
2022
Q1 		$25.9M Buy
+341,698
New +$27.1M 0.22% 107
2021
Q3 		– Sell
-301,534
Closed -$24.5M – 2268
2021
Q2 		$24.5M Buy
301,534
+201,863
+203% +$16.5M 0.28% 65
2021
Q1 		$7.86M Buy
99,671
+7,712
+8% +$604K 0.12% 187
2020
Q4 		$7.86M Sell
91,959
-47,010
-34% -$3.89M 0.11% 197
2020
Q3 		$10.7M Buy
138,969
+97,875
+238% +$7.46M 0.15% 153
2020
Q2 		$3.01M Buy
41,094
+33,321
+429% +$2.37M 0.04% 518
2020
Q1 		$516K Sell
7,773
-808
-9% -$57K 0.02% 557
2019
Q4 		$591K Buy
+8,581
New +$585K 0.02% 869
2019
Q3 		– Sell
-11,297
Closed -$810K – 280
2019
Q2 		$810K Sell
11,297
-21,826
-66% -$1.55M 0.19% 123
2019
Q1 		$2.27M Buy
33,123
+5,738
+21% +$371K 0.3% 74
2018
Q4 		$1.63M Buy
27,385
+12,811
+88% +$802K 0.7% 12
2018
Q3 		$976K Buy
14,574
+13,813
+1,815% +$920K 0.13% 125
2018
Q2 		$49K Buy
761
+47
+7% +$3.07K 0.03% 524
2018
Q1 		$51K Buy
+714
New +$51.4K 0.02% 271

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CL Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Colgate-Palmolive (CL) stake by 647% in Q1 2026, buying an estimated $187M and bringing the position to 2,421,293 shares worth $206M. The position accounts for 0.23% of the portfolio, ranked #92.

Qube Research & Technologies (QRT) first reported a position in CL in Q1 2018 and has held it in 27 quarters since. The position peaked at $406M in Q1 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,421,293 shares of Colgate-Palmolive worth $206M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 2,097,037 Colgate-Palmolive shares in Q1 2026, an estimated $187M.
  • Colgate-Palmolive made up 0.23% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #92 holding.
  • Qube Research & Technologies (QRT) first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 27 quarters since.
  • Qube Research & Technologies (QRT)'s Colgate-Palmolive position peaked at $406M in Q1 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.